Cargando…
Safety and Danger Considerations of Novel Treatments for Atopic Dermatitis in Context of Primary Cutaneous Lymphomas
The impact of new and emerging therapies on the microenvironment of primary cutaneous lymphomas (PCLs) has been recently raised in the literature. Concomitantly, novel treatments are already used or registered (dupilumab, upadacitinib) and others seem to be added to the armamentarium against atopic...
Autores principales: | Kołkowski, Karol, Trzeciak, Magdalena, Sokołowska-Wojdyło, Małgorzata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703592/ https://www.ncbi.nlm.nih.gov/pubmed/34948183 http://dx.doi.org/10.3390/ijms222413388 |
Ejemplares similares
-
Safety and danger of biologic treatments in psoriasis in context of cutaneous T-cell lymphoma (CTCL)
por: Kołkowski, Karol, et al.
Publicado: (2021) -
Expression Profiles of Genes Encoding Cornified Envelope Proteins in Atopic Dermatitis and Cutaneous T-Cell Lymphomas
por: Trzeciak, Magdalena, et al.
Publicado: (2020) -
How to Understand Personalized Medicine in Atopic Dermatitis Nowadays?
por: Mesjasz, Alicja, et al.
Publicado: (2023) -
2-Chlorodeoxyadenosine treatment for cutaneous T-cell lymphoma
por: Sokołowska-Wojdyło, Małgorzata, et al.
Publicado: (2010) -
The ambiguous pruritogenic role of interleukin-31 in cutaneous T-cell lymphomas in comparison to atopic dermatitis: a review
por: Olszewska, Berenika, et al.
Publicado: (2020)